Bradlee Heckmann (@bradleeheckmann) 's Twitter Profile
Bradlee Heckmann

@bradleeheckmann

Co-founder & Chief Scientific Officer - Asha Therapeutics • Assistant Prof USF Health

ID: 1147672925203570688

linkhttp://heckmannlab.com calendar_today07-07-2019 01:05:22

57 Tweet

387 Takipçi

308 Takip Edilen

Bradlee Heckmann (@bradleeheckmann) 's Twitter Profile Photo

Great lab meeting today, missing a few people, especially some of our Asha TX team, but it was nice to welcome our newest postdoc Ryosuke Ono! #Science #pharmacology #Neuro

Great lab meeting today, missing a few people, especially some of our Asha TX team, but it was nice to welcome our newest postdoc Ryosuke Ono! 
#Science #pharmacology #Neuro
Bradlee Heckmann (@bradleeheckmann) 's Twitter Profile Photo

Had an amazing visit and fantastic talk from the one and only ⁦⁦SchaferLabUMassChan⁩ thanks for visiting us in Tampa! #microglia #science #multiplesclerosis

Had an amazing visit and fantastic talk from the one and only ⁦⁦<a href="/SchaferLabUMass/">SchaferLabUMassChan</a>⁩ thanks for visiting us in Tampa!
#microglia #science #multiplesclerosis
Bradlee Heckmann (@bradleeheckmann) 's Twitter Profile Photo

Welcome to the lab @r_ono_37! Dr. Ryosuke Ono is our newest postdoc and is a JSPS Fellow. He is planning on studying a few different things, including mechanisms of tumor cell dormancy in metastatic brain tumors. #heckmannlab #science #CancerResearch

Welcome to the lab @r_ono_37! Dr. Ryosuke Ono is our newest postdoc and is a JSPS Fellow. He is planning on studying a few different things, including mechanisms of tumor cell dormancy in metastatic brain tumors.
#heckmannlab #science #CancerResearch
Bradlee Heckmann (@bradleeheckmann) 's Twitter Profile Photo

Great minds think alike… or is it dress alike? Meet Kelly Horn, our business manager and fiscal/grant guru. She is the heart that keeps us running and I cannot thank her enough for putting up with us non-business minded scientists!

Great minds think alike… or is it dress alike? Meet Kelly Horn, our business manager and fiscal/grant guru. She is the heart that keeps us running and I cannot thank her enough for putting up with us non-business minded scientists!
Bradlee Heckmann (@bradleeheckmann) 's Twitter Profile Photo

Congrats to our PhD student Komal Matai! Well deserved award! Love when lab members are recognized for their achievements! This one is extra sweet as Komal is helping drive life changing drug development projects at Asha Therapeutics Asha Therapeutics !!!

Congrats to our PhD student Komal Matai! Well deserved award! 

Love when lab members are recognized for their achievements! This one is extra sweet as Komal is helping drive life changing drug development projects at Asha Therapeutics <a href="/Asha_TXs/">Asha Therapeutics</a> !!!
Bradlee Heckmann (@bradleeheckmann) 's Twitter Profile Photo

First time visiting the Wellcome Sanger Institute for BRMEC-12 Conference on ME/CFS & Long COVID. Excited to share new data efficacy data for our lead Parkinson's drug ASHA-091 in models of ME/CFS. Thanks @invest_in_me (Invest in ME Research) 🇪🇺 for the invitation! #MECFS #Neurology

First time visiting the Wellcome Sanger Institute for BRMEC-12 Conference on ME/CFS &amp; Long COVID. Excited to share new data efficacy data for our lead Parkinson's drug ASHA-091 in models of ME/CFS. Thanks <a href="/Invest_in_ME/">@invest_in_me (Invest in ME Research) 🇪🇺</a> for the invitation!  #MECFS #Neurology
Bradlee Heckmann (@bradleeheckmann) 's Twitter Profile Photo

Targeting DRP1 has so many therapeutic and anti-aging potentials! This is exactly what we are doing at Asha Therapeutics with our lead highly specific DRP1 inhibitor ASHA-091, indications include Parkinson’s, Alzheimer’s, Stroke, ME/CFS and more! Ashatherapeutics.com

Bradlee Heckmann (@bradleeheckmann) 's Twitter Profile Photo

I had the pleasure of presenting data on ASHA-091 in ME/CFS last week at the BRMEC12 conference in the U.K. For those who have been asking, here is a brief overview of what was presented and some selected data. #MECFS #chronicillness #fatigue #mitochondria

Bradlee Heckmann (@bradleeheckmann) 's Twitter Profile Photo

In Boston to present new efficacy data on ASHA-044 in colorectal cancer and anti-tumor immunity! #Cancer #CRC #oncology #Immunotherapy ashatherapeutics.com/post/ngio2023

In Boston to present new efficacy data on ASHA-044 in colorectal cancer and anti-tumor immunity! 
#Cancer #CRC #oncology #Immunotherapy 

ashatherapeutics.com/post/ngio2023
Bradlee Heckmann (@bradleeheckmann) 's Twitter Profile Photo

So very true! Aging is the #1 risk factor for disease and mitochondria play a centric role in many cellular signaling processes. Can targeting mitochondrial dynamics and hyper-fragmentation slow aging? Asha Therapeutics we believe it will! #aging #disease #inflammation

Thinakaran Lab (@thinakaranlab) 's Twitter Profile Photo

Want to live and work in a fantastic place? Come to Tampa! We are #hiring at Byrd / USF Neuroscience Institute. Tenured and Tenure-Track Faculty Positions USF Health jobRxiv The PostDocs Forum #neuroscience Please RT.

Bradlee Heckmann (@bradleeheckmann) 's Twitter Profile Photo

Had a fantastic time at the BLUE KNIGHT™️ QuickPitch event at JLABS @ Washington, DC! Honored to represent our Asha Therapeutics team and thank you to Johnson & Johnson Innovation for the invitation! Great work from our team especially our COO Julia Hallisey! #startup #cure #science #medicine

Had a fantastic time at the BLUE KNIGHT™️ QuickPitch event at JLABS @ Washington, DC! Honored to represent our <a href="/Asha_TXs/">Asha Therapeutics</a> team and thank you to <a href="/JNJInnovation/">Johnson & Johnson Innovation</a> for the invitation! Great work from our team especially our COO Julia Hallisey!
#startup #cure #science #medicine
Bradlee Heckmann (@bradleeheckmann) 's Twitter Profile Photo

Big news!! Asha Therapeutics Selected as a BLUE KNIGHT™ Company by Johnson & Johnson Innovation and the Biomedical Advanced Research and Development Authority (BARDA) #medicine #science #cure prnewswire.com/news-releases/…

Sam Shrivastava, BS, MS, HI-Cancer Research HMS. (@shrivastava_sam) 's Twitter Profile Photo

Asha Therapeutics to Present at AD/PD™ 2024 International Conference and Announces Clinical Development Plan for Lead Programs Anticipated to Enter Clinical Trials this Year and Welcomes Two New SAB Members | Business Wire businesswire.com/news/home/2024…

Bradlee Heckmann (@bradleeheckmann) 's Twitter Profile Photo

Proud of our team to say the least! Asha Therapeutics to Present at AD/PD™ 2024 International Conference and Announces Clinical Development Plan for Lead Programs Anticipated to Enter Clinical Trials this Year and Welcomes Two New SAB Members - businesswire.com/news/home/2024…

Bradlee Heckmann (@bradleeheckmann) 's Twitter Profile Photo

Another significant step forward and opportunity to recognize all of the Asha team for their passion for our vision of radically improving patient health outcomes for devastating diseases. #ALS #Alzheimers #medicine #cure #mecfs businesswire.com/news/home/2024…

Bradlee Heckmann (@bradleeheckmann) 's Twitter Profile Photo

Proud mentor moment! Our student jeremy rocking his presentation! We have been very blessed to have not only brilliant, but driven students in the lab!

Proud mentor moment! Our student <a href="/jeremyvtheworld/">jeremy</a> rocking his presentation!  We have been very blessed to have not only brilliant, but driven students in the lab!